116 related articles for article (PubMed ID: 27196762)
1. Suppression of SRC Signaling Is Effective in Reducing Synergy between Glioblastoma and Stromal Cells.
Calgani A; Vignaroli G; Zamperini C; Coniglio F; Festuccia C; Di Cesare E; Gravina GL; Mattei C; Vitale F; Schenone S; Botta M; Angelucci A
Mol Cancer Ther; 2016 Jul; 15(7):1535-44. PubMed ID: 27196762
[TBL] [Abstract][Full Text] [Related]
2. Proton Therapy and Src Family Kinase Inhibitor Combined Treatments on U87 Human Glioblastoma Multiforme Cell Line.
Cammarata FP; Torrisi F; Forte GI; Minafra L; Bravatà V; Pisciotta P; Savoca G; Calvaruso M; Petringa G; Cirrone GAP; Fallacara AL; Maccari L; Botta M; Schenone S; Parenti R; Cuttone G; Russo G
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31554327
[TBL] [Abstract][Full Text] [Related]
3. Blockade of TGF-β signaling by the TGFβR-I kinase inhibitor LY2109761 enhances radiation response and prolongs survival in glioblastoma.
Zhang M; Kleber S; Röhrich M; Timke C; Han N; Tuettenberg J; Martin-Villalba A; Debus J; Peschke P; Wirkner U; Lahn M; Huber PE
Cancer Res; 2011 Dec; 71(23):7155-67. PubMed ID: 22006998
[TBL] [Abstract][Full Text] [Related]
4. Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors.
Lokker NA; Sullivan CM; Hollenbach SJ; Israel MA; Giese NA
Cancer Res; 2002 Jul; 62(13):3729-35. PubMed ID: 12097282
[TBL] [Abstract][Full Text] [Related]
5. SRC Tyrosine Kinase Inhibitor and X-rays Combined Effect on Glioblastoma Cell Lines.
Torrisi F; Minafra L; Cammarata FP; Savoca G; Calvaruso M; Vicario N; Maccari L; Pérès EA; Özçelik H; Bernaudin M; Botta L; Russo G; Parenti R; Valable S
Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32486205
[TBL] [Abstract][Full Text] [Related]
6. SRC family kinase inhibition through a new pyrazolo[3,4-d]pyrimidine derivative as a feasible approach for glioblastoma treatment.
Ceccherini E; Indovina P; Zamperini C; Dreassi E; Casini N; Cutaia O; Forte IM; Pentimalli F; Esposito L; Polito MS; Schenone S; Botta M; Giordano A
J Cell Biochem; 2015 May; 116(5):856-63. PubMed ID: 25521525
[TBL] [Abstract][Full Text] [Related]
7. Src Inhibitors Pyrazolo[3,4-d]pyrimidines, Si306 and Pro-Si306, Inhibit Focal Adhesion Kinase and Suppress Human Glioblastoma Invasion In Vitro and In Vivo.
Nešović M; Divac Rankov A; Podolski-Renić A; Nikolić I; Tasić G; Mancini A; Schenone S; Pešić M; Dinić J
Cancers (Basel); 2020 Jun; 12(6):. PubMed ID: 32545852
[TBL] [Abstract][Full Text] [Related]
8. ST-11: A New Brain-Penetrant Microtubule-Destabilizing Agent with Therapeutic Potential for Glioblastoma Multiforme.
Cherry AE; Haas BR; Naydenov AV; Fung S; Xu C; Swinney K; Wagenbach M; Freeling J; Canton DA; Coy J; Horne EA; Rickman B; Vicente JJ; Scott JD; Ho RJ; Liggitt D; Wordeman L; Stella N
Mol Cancer Ther; 2016 Sep; 15(9):2018-29. PubMed ID: 27325686
[TBL] [Abstract][Full Text] [Related]
9. Identification of two glioblastoma-associated stromal cell subtypes with different carcinogenic properties in histologically normal surgical margins.
Clavreul A; Etcheverry A; Tétaud C; Rousseau A; Avril T; Henry C; Mosser J; Menei P
J Neurooncol; 2015 Mar; 122(1):1-10. PubMed ID: 25503303
[TBL] [Abstract][Full Text] [Related]
10. TLK2 enhances aggressive phenotypes of glioblastoma cells through the activation of SRC signaling pathway.
Lin M; Yao Z; Zhao N; Zhang C
Cancer Biol Ther; 2019; 20(1):101-108. PubMed ID: 30207834
[TBL] [Abstract][Full Text] [Related]
11. Enhanced antitumor effect of YM872 and AG1296 combination treatment on human glioblastoma xenograft models.
Watanabe T; Ohtani T; Aihara M; Ishiuchi S
J Neurosurg; 2013 Apr; 118(4):838-45. PubMed ID: 23311938
[TBL] [Abstract][Full Text] [Related]
12. Molecular crosstalk between tumour and brain parenchyma instructs histopathological features in glioblastoma.
Bougnaud S; Golebiewska A; Oudin A; Keunen O; Harter PN; Mäder L; Azuaje F; Fritah S; Stieber D; Kaoma T; Vallar L; Brons NH; Daubon T; Miletic H; Sundstrøm T; Herold-Mende C; Mittelbronn M; Bjerkvig R; Niclou SP
Oncotarget; 2016 May; 7(22):31955-71. PubMed ID: 27049916
[TBL] [Abstract][Full Text] [Related]
13. AuNP Pyrazolo[3,4-
Molinari A; Iovenitti G; Mancini A; Gravina GL; Chebbi M; Caruana M; Vignaroli G; Orofino F; Rango E; Angelucci A; Dreassi E; Schenone S; Botta M
ACS Med Chem Lett; 2020 May; 11(5):664-670. PubMed ID: 32435368
[TBL] [Abstract][Full Text] [Related]
14. Metformin Suppresses Tumor Progression by Inactivating Stromal Fibroblasts in Ovarian Cancer.
Xu S; Yang Z; Jin P; Yang X; Li X; Wei X; Wang Y; Long S; Zhang T; Chen G; Sun C; Ma D; Gao Q
Mol Cancer Ther; 2018 Jun; 17(6):1291-1302. PubMed ID: 29545331
[TBL] [Abstract][Full Text] [Related]
15. Dual mTORC1/2 blockade inhibits glioblastoma brain tumor initiating cells in vitro and in vivo and synergizes with temozolomide to increase orthotopic xenograft survival.
Luchman HA; Stechishin OD; Nguyen SA; Lun XQ; Cairncross JG; Weiss S
Clin Cancer Res; 2014 Nov; 20(22):5756-67. PubMed ID: 25316808
[TBL] [Abstract][Full Text] [Related]
16. Autophagy Inhibition Enhances Anti-Glioblastoma Effects of Pyrazolo[3,4-
Jovanović Stojanov S; Kostić A; Ljujić M; Lupšić E; Schenone S; Pešić M; Dinić J
Life (Basel); 2022 Sep; 12(10):. PubMed ID: 36294938
[TBL] [Abstract][Full Text] [Related]
17. Analysis Suggests Drug Combos for Glioblastoma.
Cancer Discov; 2016 Jun; 6(6):OF2. PubMed ID: 27165727
[TBL] [Abstract][Full Text] [Related]
18. Enhanced expression of proapoptotic and autophagic proteins involved in the cell death of glioblastoma induced by synthetic glycans.
Faried A; Arifin MZ; Ishiuchi S; Kuwano H; Yazawa S
J Neurosurg; 2014 Jun; 120(6):1298-308. PubMed ID: 24678780
[TBL] [Abstract][Full Text] [Related]
19. Fibroblast activation protein alpha is expressed by transformed and stromal cells and is associated with mesenchymal features in glioblastoma.
Busek P; Balaziova E; Matrasova I; Hilser M; Tomas R; Syrucek M; Zemanova Z; Krepela E; Belacek J; Sedo A
Tumour Biol; 2016 Oct; 37(10):13961-13971. PubMed ID: 27492457
[TBL] [Abstract][Full Text] [Related]
20. Glioblastoma-associated stromal cells (GASCs) from histologically normal surgical margins have a myofibroblast phenotype and angiogenic properties.
Clavreul A; Guette C; Faguer R; Tétaud C; Boissard A; Lemaire L; Rousseau A; Avril T; Henry C; Coqueret O; Menei P
J Pathol; 2014 May; 233(1):74-88. PubMed ID: 24481573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
